1. HBW Insight
  2. >>Geography
  3. >>International

With TheraTears, Prestige Consumer Sees Way To Boost Guidance Despite COVID, Cost Uncertainties

 
• By Malcolm Spicer

More than 17% growth in consumer health product sales in latest quarter on top of adding TheraTears brands to its lineup at start of current quarter outweighs potential headwinds from costs and changes in consumer spending, Prestige Consumer executives say.

Prestige Consumer Healthcare starts its FY2022 with higher returns in sales, net income and EPS driven by higher spending on advertising/marketing and on costs of goods sold.

Prestige Consumer Healthcare Inc. didn’t let “a lot of uncertainty” about supply chain costs and consumer spending linked to COVID-19 stop it from increasing its earnings guidance.

More than 17% growth in its OTC drug and other consumer health product sales in its latest quarter on top of adding the TheraTears brands to its lineup at the start of the current quarter outweighs potential headwinds from costs and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

More from Geography